Protenus Is Acquired by Bluesight

Healthcare

Protenus sale to Bluesight, a portfolio company of Thoma Bravo


Summary

Protenus, Inc. ("Protenus” or the "Company”), has been acquired by Bluesight, Inc. ("Bluesight”), a portfolio company of Thoma Bravo, LP ("Thoma Bravo”). Terms of the transaction were not disclosed.

Baird served as exclusive financial advisor to Protenus on this transaction.

About

Protenus harnesses the power of AI to provide healthcare organizations with scalable risk-reduction solutions that drive the safest patient outcomes while protecting the reputation of the organizations. The Company is committed to innovation, determined to reduce risk and focused on supporting its community of employees, customers and ultimately, patients. Protenus is headquartered in Baltimore, Maryland.

Bluesight powers hospital and pharmacy operations with intelligence that simplifies inventory management, procurement and compliance. Through its suite of industry-leading solutions, Bluesight ensures that health systems protect every patient and optimize every dollar. Over 2,400 United States and Canadian hospitals rely on Bluesight every day to have efficient and safe operations. Bluesight is headquartered in Alexandria, Virginia.

Thoma Bravo is one of the largest software-focused investors in the world, with over US$166 billion in assets under management as of September 30, 2024. Through its private equity, growth equity and credit strategies, the firm invests in growth-oriented, innovative companies operating in the software and technology sectors. Leveraging Thoma Bravo's deep sector knowledge and strategic and operational expertise, the firm collaborates with its portfolio companies to implement operating best practices and drive growth initiatives. Over the past 20+ years, the firm has acquired or invested in more than 500 companies representing approximately US$265 billion in enterprise value (including control and non-control investments). Thoma Bravo has offices in Dallas, London, Miami, New York and San Francisco and is headquartered in Chicago, Illinois.
CONTACT US TO LEARN MORE
Healthcare

Protenus sale to Bluesight, a portfolio company of Thoma Bravo

Date
January 2025
Company
Protenus, Inc.
Transaction
M&A - Sellside
Sectors
Healthcare
Verticals
Healthcare IT & Services
Target Geography
North America
Acquiror Geography
North America

Share